Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin

  • Zhonggen Shi
  • Rui Guo
  • Weichang Li
  • Yi Zhang
  • Wei Xue
  • Yu Tang
  • Yuanming Zhang
Article

Abstract

Chitosan (CS) was first modified hydrophobically with deoxycholic acid (DCA) and then with polyethylene glycol (PEG) to obtain a novel amphiphilic polymer (CS–DCA–PEG). This was covalently bound to folic acid (FA) to develop nanoparticles (CS–DCA–PEG–FA) with tumor cell targeting property. The structure of the conjugates was characterised using Fourier transform infrared and 1H nuclear magnetic resonance spectroscopy and X-ray diffraction. Based on self-aggregation, the conjugates formed nanoparticles with a low critical aggregation concentration of 0.035 mg/ml. The anti-cancer drug doxorubicin (DOX) was encapsulated into the nanoparticles with a drug-loading capacity of 30.2 wt%. The mean diameter of the DOX-loaded nanoparticles was about 200 nm, with a narrow size distribution. Transmission electron microscopy images showed that the DOX-loaded nanoparticles were spherical. The drug release was studied under different conditions. Furthermore, the cytotoxic activities of DOX in CS–DCA–PEG–FA nanoparticles against folate receptor (FR)-positive HeLa cells and FR-negative fibroblast 3T3 cells were evaluated. These results suggested that the CS–DCA–PEG–FA nanoparticles may be a promising vehicle for the targeting anticancer drug to tumor cells.

Keywords

Folic Acid Pyrene Encapsulation Efficiency Sodium Acetate Buffer Amphiphilic Polymer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

This study is financially supported by the Natural Science Foundation of Guangdong (S2012040008003), Guangzhou Science and Technology Plan Project (No. 11C32070752), the Key Project of DEGP (cxzd1109), the Ph.D. Programs Foundation of Ministry of Education of China and the Fundamental Research Funds for the Central Universities (21612327). This research is financially supported by Guangzhou Science and Technology Plan Project (No. 11C32070752).

References

  1. 1.
    Sahu SK, Maiti S, Maiti TK, Ghosh SK, Pramanik P. Hydrophobically modified carboxymethyl chitosan nanoparticles targeted delivery of paclitaxel. J Drug Target. 2011;19:104–13.CrossRefGoogle Scholar
  2. 2.
    Wang FH, Zhang DR, Duan CX, et al. Preparation and characterizations of a novel deoxycholic acid-O-carboxymethylated chitosan–folic acid conjugates and self-aggregates. Carbohyd Polym. 2011;84:1192–200.CrossRefGoogle Scholar
  3. 3.
    Ohya Y, Takeda S, Shibata Y, Ouchi T, Maruyama A. Preparation of highly stable biodegradable polymer micelles by coating with polyion complex. Macromol Chem Phys. 2010;211:1750–6.CrossRefGoogle Scholar
  4. 4.
    Huo MR, Zhang Y, Zhou JP, et al. Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug. Int J Pharmaceut. 2010;394:162–73.CrossRefGoogle Scholar
  5. 5.
    Li PW, Wang YC, Zeng FB, Chen LJ, Peng Z, Kong LX. Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells. Carbohyd Res. 2011;346:801–6.CrossRefGoogle Scholar
  6. 6.
    Zhou HF, Yu WT, Guo X, et al. Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin. Biomacromolecules. 2010;11:3480–6.CrossRefGoogle Scholar
  7. 7.
    Jin YH, Hu HY, Qiao MX, et al. pH-sensitive chitosan-derived nanoparticles as doxorubicin carriers for effective anti-tumor activity: preparation and in vitro evaluation. Colloid Surface B. 2012;94:184–91.CrossRefGoogle Scholar
  8. 8.
    Cao MY, Jin HX, Ye WJ, Liu P, Wang LQ, Jiang HL. A convenient scheme for synthesizing reduction-sensitive chitosan-based amphiphilic copolymers for drug delivery. J Appl Polym Sci. 2012;123:3137–44.CrossRefGoogle Scholar
  9. 9.
    Wang BQ, He CB, Tang C, Yin CH. Effects of hydrophobic and hydrophilic modifications on gene delivery of amphiphilic chitosan based nanocarriers. Biomaterials. 2011;32:4630–8.CrossRefGoogle Scholar
  10. 10.
    Wang J, Zong JY, Zhao D, Zhuo RX, Cheng SX. In situ formation of chitosan–cyclodextrin nanospheres for drug delivery. Colloid Surface B. 2011;87:198–202.CrossRefGoogle Scholar
  11. 11.
    Zeng P, Xu Y, Zeng CH, Ren H, Peng ML. Chitosan-modified poly(d,l-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing. Int J Pharmaceut. 2011;415:259–66.CrossRefGoogle Scholar
  12. 12.
    Huynh DP, Nguyen MK, Pi BS, et al. Functionalized injectable hydrogels for controlled insulin delivery. Biomaterials. 2008;29:2527–34.CrossRefGoogle Scholar
  13. 13.
    Gao JQ, Zhao QQ, Lv TF, et al. Gene-carried chitosan-linked-PEI induced high gene transfection efficiency with low toxicity and significant tumor-suppressive activity. Int J Pharmaceut. 2010;387:286–94.CrossRefGoogle Scholar
  14. 14.
    Huh MS, Lee SY, Park S, et al. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice. J Control Release. 2010;144:134–43.CrossRefGoogle Scholar
  15. 15.
    Duan CX, Zhang DR, Wang FH, et al. Chitosan-g-poly(N-isopropylacrylamide) based nanogels for tumor extracellular targeting. Int J Pharmaceut. 2011;409:252–9.CrossRefGoogle Scholar
  16. 16.
    Cai GQ, Jiang HL. pH-sensitive nanoparticles self-assembled from a novel class of biodegradable amphiphilic copolymers based on chitosan. J Mater Sci-Mater M. 2009;20:1315–20.CrossRefGoogle Scholar
  17. 17.
    Yang SJ, Chang SM, Tsai KC, Tsai HM, Chen WS, Shieh MJ. Enhancement of chitosan nanoparticle-facilitated gene transfection by ultrasound both in vitro and in vivo. J Biomed Mater Res B. 2012;100B:1746–54.CrossRefGoogle Scholar
  18. 18.
    Wang XH, Tian Q, Wang W, Zhang CN, Wang P, Yuan Z. In vitro evaluation of polymeric micelles based on hydrophobically-modified sulfated chitosan as a carrier of doxorubicin. J Mater Sci-Mater M. 2012;23:1663–74.CrossRefGoogle Scholar
  19. 19.
    Du J, Zhang S, Sun R, Zhang LF, Xiong CD, Peng YX. Novel polyelectrolyte carboxymethyl konjac glucomannan–chitosan nanoparticles for drug delivery. II. Release of albumin in vitro. J Biomed Mater Res B. 2005;72B:299–304.CrossRefGoogle Scholar
  20. 20.
    Duan JH, Liu MJ, Zhang YD, Zhao JF, Pan YF, Yang XY. Folate-decorated chitosan/doxorubicin poly(butyl)cyanoacrylate nanoparticles for tumor-targeted drug delivery. J Nanopart Res. 2012;14.Google Scholar
  21. 21.
    Galbiati A, Tabolacci C, DellaRocca BM, et al. Targeting tumor cells through chitosan–folate modified microcapsules loaded with camptothecin. Bioconjugate Chem. 2011;22:1066–72.CrossRefGoogle Scholar
  22. 22.
    Lee KY, Kim JH, Kwon IC, Jeong SY. Self-aggregates of deoxycholic acid modified chitosan as a novel carrier of adriamycin. Colloid Polym Sci. 2000;278:1216–9.CrossRefGoogle Scholar
  23. 23.
    Wang F, Chen Y, Zhang D, et al. Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-O-carboxymethylated chitosan–folic acid micelles. Int J Nanomed. 2012;7:325–37.Google Scholar
  24. 24.
    Wang F, Zhang D, Duan C, et al. Preparation and characterizations of a novel deoxycholic acid-O-carboxymethylated chitosan–folic acid conjugates and self-aggregates. Carbohyd Polym. 2011;84:1192–200.CrossRefGoogle Scholar
  25. 25.
    Lv PP, Ma YF, Yu R, et al. Targeted delivery of insoluble cargo (Paclitaxel) by PEGylated chitosan nanoparticles grafted with Arg-Gly-Asp (RGD). Mol Pharmaceut. 2012;9:1736–47.CrossRefGoogle Scholar
  26. 26.
    Hou ZQ, Zhan CM, Jiang QW, Hu Q, Li L, Chang D, et al. Both FA- and mPEG-conjugated chitosan nanoparticles for targeted cellular uptake and enhanced tumor tissue distribution. Nanoscale Res Lett. 2011;6.Google Scholar
  27. 27.
    Oh NM, Oh KT, Baik HJ, et al. A self-organized 3-diethylaminopropyl-bearing glycol chitosan nanogel for tumor acidic pH targeting: in vitro evaluation. Colloid Surface B. 2010;78:120–6.CrossRefGoogle Scholar
  28. 28.
    Wang HJ, Zhao PQ, Liang XF, et al. Folate-PEG coated cationic modified chitosan—cholesterol liposomes for tumor-targeted drug delivery. Biomaterials. 2010;31:4129–38.CrossRefGoogle Scholar
  29. 29.
    Hwang HY, Kim IS, Kwon IC, Kim YH. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J Control Release. 2008;128:23–31.CrossRefGoogle Scholar
  30. 30.
    Shen JM, Tang WJ, Zhang XL, Chen T, Zhang HX. A novel carboxymethyl chitosan-based folate/Fe3O4/CdTe nanoparticle for targeted drug delivery and cell imaging. Carbohyd Polym. 2012;88:239–49.CrossRefGoogle Scholar
  31. 31.
    Kulkarni AR, Lin YH, Liang HF, Chang WC, Hsiao WW, Sung HW. A novel method for the preparation of nanoaggregates of methoxy polyethyleneglycol linked chitosan. J Nanosci Nanotechnol. 2006;6:2867–73.CrossRefGoogle Scholar
  32. 32.
    Mansouri S, Cuie Y, Winnik F, et al. Characterization of folate–chitosan-DNA nanoparticles for gene therapy. Biomaterials. 2006;27:2060–5.CrossRefGoogle Scholar
  33. 33.
    Ji JG, Wu DJ, Liu L, Chen JD, Xu Y. Preparation, characterization, and in vitro release of folic acid-conjugated chitosan nanoparticles loaded with methotrexate for targeted delivery. Polym Bull. 2012;68:1707–20.CrossRefGoogle Scholar
  34. 34.
    Yue ZG, Wei W, Lv PP, et al. Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. Biomacromolecules. 2011;12:2440–6.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Zhonggen Shi
    • 1
    • 2
  • Rui Guo
    • 1
    • 3
  • Weichang Li
    • 1
    • 2
  • Yi Zhang
    • 1
    • 3
  • Wei Xue
    • 1
    • 3
  • Yu Tang
    • 1
    • 2
  • Yuanming Zhang
    • 1
    • 2
  1. 1.Key Laboratory of Biomaterials of Guangdong Higher Education InstitutesJinan UniversityGuangzhouChina
  2. 2.Department of ChemistryJinan UniversityGuangzhouChina
  3. 3.Department of Biomedical EngineeringJinan UniversityGuangzhouChina

Personalised recommendations